AMENDMENT TO INVESTMENT ADVISORY AGREEMENTInvestment Advisory Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Investment Advisory Agreement entered into on August 1, 2011 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) retained Galileo Asset Management, SA, a Swiss Corporation and member of the OAR-G (Organisme D’Autoregulation Des Gerants De Patrimoine) with headquarters located at the World Trade Center, Avenue Gratta-Paille 2, Case Postale 4767, CH –1000 Lausanne 30, Switzerland (the “Advisor”), render services as defined in the Original Agreement, is hereby made in order to amend Section 2 of the Original Agreement with regard to Advisor’s Compensation.
RADIENT PHAMACEUTICALS CORPORATIONRadient Phamaceuticals Corporation • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • California
This Consulting Agreement (“Agreement”) is made by and with Cantone Asset Management, LLC, an independent consultant, principally doing business at 439 Wrighter Lake Road, P.O. Box 43, Thompson, Pennsylvania 18465 (“Consultant”), and Radient Pharmaceuticals Corporation (“Client”) of 2492 Walnut Avenue, Suite 100, Tustin, CA 92780. This Agreement is effective on January 1, 2011.
CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
This Consulting Agreement Amendment (the "Amendment") is made and entered into this 7th day of August 2011, to be effective as of June 1, 2011 (the "Effective Date"). It is an amendment to an ongoing agreement by and between Radient Pharmaceuticals Inc., located at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-6953 (the "Company") and JFS Investments located at 35 Crest Loop, Staten Island, NY 10312, a Florida Corporation("the Consultant").
AMENDMENT TO ADVISORY AGREEMENTAdvisory Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Advisory Agreement entered into on August 1, 2010 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039,(“The Company”) retained Garden State Securities Inc., a FINRA member firm (“GSS”), to render services as defined in the Original Agreement, is hereby made in order to amend Section 3 of the Original Agreement with regard to GSS's Compensation.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Consulting Agreement entered into on May 1, 2011 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) retained First International Capital Group, Ltd., a BVI company with offices located at: Avenue De Champel 8C, Geneva, Switzerland (hereinafter referred to as the "Consultant") to render services as defined in the Original Agreement, is hereby made in order to amend Section V of the Original Agreement with regard to Consultant’s Compensation.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Consulting Agreement entered into on May 1, 2011 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) entered into the Original Agreement whereby Catawba Global, Ltd., a BVI company with offices located at: 22 rue de la Berra, 1630 Bulle, Switzerland (hereinafter referred to as the "Consultant") agreed to render services as defined in the Original Agreement, is hereby made in order to amend Section V of the Original Agreement with regard to Consultant’s Compensation.
DEBENTURE AMENDMENTDebenture Amendment • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
This DEBENTURE AMENDMENT (this “Amendment”) is dated as of March 17, 2011 by and among Jade Pharmaceuticals. Inc., a British Virgin Islands corporation (the “Company”), and _________________________________ (the “Holder”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Subscription Agreement (as defined below).
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Consulting Agreement entered into on August __, 2011 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) retained BRIGHTON CAPITAL, LTD., a California corporation with its principal offices at 1875 Century Park East, Suite, 700, Los Angeles, CA 90067 (“Brighton”), to render strategic advisory services as defined in the Original Agreement, is hereby made in order to amend Section 2of the Original Agreement with regard to Brighton’s Compensation.
CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Delaware
Catawba Global, Ltd., a BVI company with offices located at: 22 rue de la Berra, 1630 Bulle, Switzerland (hereinafter referred to as the "Consultant").
CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Delaware
First International Capital Group, Ltd., a BVI company with offices located at: Avenue De Champel 8C, Geneva, Switzerland (hereinafter referred to as the "Consultant").
CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AGREEMENT (“Agreement”), dated this __ day of August 2011, to be effective as of July 15, 2011 (the “Effective Date”), confirms that RADEINT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) have retained BRIGHTON CAPITAL, LTD., a California corporation with its principal offices at 1875 Century Park East, Suite, 700, Los Angeles, CA 90067 (“Brighton”), for the purposes described in this Agreement in accordance with the terms and conditions specified herein, and Brighton has agreed to such engagement.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS AMENDMENT to the Advisory Agreement entered into on June 1, 2011 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, its subsidiaries and affiliates (“The Company”) retained JFS Investments located at 35 Crest Loop, Staten Island, NY 10312, a Florida Corporation (''the Consultant") to render services as defined in the Original Agreement, is hereby made in order to amend Section 2 of the Original Agreement with regard to Consultant’s Compensation.
INVESTMENT ADVISORY AGREEMENT BETWEEN RADIENT PHARMACEUTICALS CORP., AND GALILEO ASSET MANAGEMENT SAInvestment Advisory Agreement • February 14th, 2012 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
THIS AGREEMENT (the "Agreement") dated as August 1, 2011 by and between between Radient Pharmaceuticals Corp.. ("RPC") having its principal business at 2492 Walnut Avenue, Suite 100, Tustin, California 92780 (the "Company") and Galileo Asset Management, SA, a Swiss Corporation and member of the OAR-G (Organisme D'Autoregulation Des Gerants De Patrimoine) with headquarters located at the World Trade Center, Avenue Gratta-Paille 2, Case Postale 4767, CH – 1000 Lausanne 30, Switzerland (the "Advisor").
